Literature DB >> 30691645

Preparation and electroporation of Cas12a/Cpf1-guide RNA complexes for introducing large gene deletions in mouse embryonic stem cells.

Lucas Kissling1, Asun Monfort2, Daan C Swarts3, Anton Wutz4, Martin Jinek5.   

Abstract

CRISPR-Cas12a is a bacterial RNA-guided deoxyribonuclease that has been adopted for genetic engineering in a broad variety of organisms. Here, we describe protocols for the preparation and application of AsCas12a-guide RNA ribonucleoprotein (RNP) complexes for engineering gene deletions in mouse embryonic stem (ES) cells. We provide detailed protocols for purification of an NLS-containing AsCas12a-eGFP fusion protein, design of guide RNAs, assembly of RNP complexes, and transfection of mouse ES cells by electroporation. In addition, we present data illustrating the use of pairs of Cas12a nucleases for engineering large genetic deletions and outline experimental considerations for applications of Cas12a nucleases in ES cells.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR; Cas; Cas12a; Cas9; Embryonic stem cells; Genetic engineering; Genome editing

Mesh:

Substances:

Year:  2019        PMID: 30691645     DOI: 10.1016/bs.mie.2018.10.028

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  8 in total

1.  Electroporation of AsCpf1/RNP at the Zygote Stage is an Efficient Genome Editing Method to Generate Knock-Out Mice Deficient in Leukemia Inhibitory Factor.

Authors:  Yeon Sun Kim; Gyeong Ryeong Kim; Mira Park; Seung Chel Yang; So Hee Park; Ji Eun Won; Ju Hee Lee; Ha Eun Shin; Haengseok Song; Hye-Ryun Kim
Journal:  Tissue Eng Regen Med       Date:  2019-11-19       Impact factor: 4.169

2.  TMED2 binding restricts SMO to the ER and Golgi compartments.

Authors:  Giulio Di Minin; Markus Holzner; Alice Grison; Charles E Dumeau; Wesley Chan; Asun Monfort; Loydie A Jerome-Majewska; Henk Roelink; Anton Wutz
Journal:  PLoS Biol       Date:  2022-03-30       Impact factor: 8.029

3.  Targeted Modification of Mammalian DNA by a Novel Type V Cas12a Endonuclease from Ruminococcus bromii.

Authors:  Ruslan Vasilev; Natalia Gunitseva; Regina Shebanova; Aleksei Korzhenkov; Anna Vlaskina; Marta Evteeva; Irina Polushkina; Natalia Nikitchina; Stepan Toshchakov; Piotr Kamenski; Maxim Patrushev; Ilya Mazunin
Journal:  Int J Mol Sci       Date:  2022-08-18       Impact factor: 6.208

4.  Efficient Cas9-based Genome Editing Using CRISPR Analysis Webtools in Severe Early-onset-obesity Patient-derived iPSCs.

Authors:  Achchhe Patel; Grazia Iannello; Alejandro Garcia Diaz; Dario Sirabella; Vidhu Thaker; Barbara Corneo
Journal:  Curr Protoc       Date:  2022-08

5.  CRISPR-Cas12a delivery by DNA-mediated bioresponsive editing for cholesterol regulation.

Authors:  Wujin Sun; Jinqiang Wang; Quanyin Hu; Xingwu Zhou; Ali Khademhosseini; Zhen Gu
Journal:  Sci Adv       Date:  2020-05-20       Impact factor: 14.136

6.  Introducing gene deletions by mouse zygote electroporation of Cas12a/Cpf1.

Authors:  Charles-Etienne Dumeau; Asun Monfort; Lucas Kissling; Daan C Swarts; Martin Jinek; Anton Wutz
Journal:  Transgenic Res       Date:  2019-09-03       Impact factor: 2.788

7.  CRISPR-AsCas12a Efficiently Corrects a GPR143 Intronic Mutation in Induced Pluripotent Stem Cells from an Ocular Albinism Patient.

Authors:  Simona Torriano; Edouard Baulier; Alejandro Garcia Diaz; Barbara Corneo; Debora B Farber
Journal:  CRISPR J       Date:  2022-06

8.  RNA-Guided AsCas12a- and SpCas9-Catalyzed Knockout and Homology Directed Repair of the Omega-1 Locus of the Human Blood Fluke, Schistosoma mansoni.

Authors:  Wannaporn Ittiprasert; Chawalit Chatupheeraphat; Victoria H Mann; Wenhui Li; André Miller; Taiwo Ogunbayo; Kenny Tran; Yousef N Alrefaei; Margaret Mentink-Kane; Paul J Brindley
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.